SCHEMBL7267261

SCHEMBL7267261

Cc1[c]ncn1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38
NPSR1 Q6W5P4 2/20 0.31
MEN1 O00255 1/20 0.31
SLC22A1 O15245 1/20 0.31
KCNN4 O15554 1/20 0.31
NR1I2 O75469 1/20 0.31
GMNN O75496 1/20 0.31
USP2 O75604 1/20 0.31
TRPM2 O94759 1/20 0.31
ABCB11 O95342 1/20 0.31
EGFR P00533 1/20 0.31
CA2 P00918 1/20 0.31
LMNA P02545 1/20 0.31
NR3C1 P04150 1/20 0.31
ERBB2 P04626 1/20 0.31
TP53 P04637 1/20 0.31
CYP17A1 P05093 1/20 0.31
CYP1A2 P05177 1/20 0.31
FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7374653 0.77 CYP11B1 (0.35) CYP11B1CYP11B2KCNN4
SCHEMBL4806085 0.68 CYP11B1 (0.43) CYP11B1CYP11B2NPSR1MEN1SLC22A1
SCHEMBL10439558 0.68 CYP1A2 (0.44) CYP11B1CYP11B2NPSR1MEN1SLC22A1
SCHEMBL7268178 0.67 CYP11B1 (0.34) CYP11B1CYP11B2
SCHEMBL643163 0.66 CYP11B1 (0.37) CYP11B1CYP11B2NPSR1MEN1SLC22A1
SCHEMBL643809 0.66 CYP11B1 (0.37) CYP11B1CYP11B2NPSR1MEN1SLC22A1
SCHEMBL10439557 0.66 CYP11B1 (0.37) CYP11B1CYP11B2NPSR1MEN1SLC22A1
SCHEMBL30577371 0.65 CYP11B1 (0.57) CYP11B1CYP11B2NPSR1MEN1SLC22A1
SCHEMBL3855448 0.64 NSD3 (0.38) CYP11B1CYP11B2NPSR1MEN1USP2
SCHEMBL4884756 0.64 CYP11B1 (0.35) CYP11B1CYP11B2NPSR1KCNN4USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5866598-A 4H-CARBAZOL-4-ONES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-02-02 US disclosed
US-5698561-A PYRIDO(1,2-A)INDOLE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-12-16 US disclosed
US-5607938-A Medicament for treating or preventing cerebrovascular infarction FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-03-04 US disclosed
EP-0451538-B1 Use of pyridoindole derivatives in the treatment of ischemic disorders FUJISAWA PHARMACEUTICAL CO (JP) 1996-05-22 EP disclosed
EP-0688216-A1 MEDICAMENT FOR TREATING OR PREVENTING CEREBROVASCULAR DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-12-27 EP disclosed
EP-0420086-B1 Pyrimidoindole derivatives and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1995-12-13 EP disclosed
EP-0361317-B1 Pyridoindole derivatives and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1995-04-05 EP disclosed
WO-1994020102-A2 MEDICAMENT FOR TREATING OR PREVENTING CEREBROVASCULAR DISEASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-09-15 WO disclosed
US-5290785-A Therapeutic agent for ischemic diseases FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-03-01 US disclosed
US-5256780-A Serotonin antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-10-26 US disclosed
US-5180728-A Antagonists of 5-hydroxytryptamine FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1993-01-19 US disclosed
US-5173493-A For treatment or prevention of nausea or vomiting FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-12-22 US disclosed
US-5141945-A 5-Hydroxytryptamine antagonists, treatment or prevention of nausea and vomiting FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-08-25 US disclosed
EP-0451538-A2 Use of pyridoindole derivatives in the treatment of ischemic disorders FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-10-16 EP disclosed
EP-0420086-A2 Pyrimidoindole derivatives and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-04-03 EP disclosed
EP-0361317-A2 Pyridoindole derivatives and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-04-04 EP disclosed